docetaxel anhydrous has been researched along with 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine) | Trials (5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine) | Recent Studies (post-2010) (5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 273 | 0 | 99 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jayakumar, R; Lakshmanan, VK; Maya, S; Menon, D; Sarmento, B | 1 |
1 other study(ies) available for docetaxel anhydrous and 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine
| Article | Year |
|---|---|
Actively targeted cetuximab conjugated gamma-poly(glutamic acid)-docetaxel nanomedicines for epidermal growth factor receptor over expressing colon cancer cells.
Topics: Animals; Annexins; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzimidazoles; Carbocyanines; Cell Cycle; Cell Death; Cetuximab; Colonic Neoplasms; Docetaxel; Drug Carriers; ErbB Receptors; Hemolysis; HT29 Cells; Humans; Mice; Nanomedicine; Nanoparticles; Polyglutamic Acid; Taxoids; Tissue Distribution | 2014 |